Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Oct 14;8(2):e001188. doi: 10.1136/jitc-2020-001188

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.

PMC Copyright notice

Nomogram predicting the probability of 5-year recurrence-free survival (RFS) and calibration plots. (A) A nomogram incorporating the presence of TLS, WHO classification and AJCC^8th TNM stage. (B) Calibration curve for predicting the probability of 5-year RFS using the nomogram (A) on the Fudan cohort. (C) Calibration curve for predicting the probability of 5-year RFS using the nomogram (A) on the external validation set. (D) The MSKCC-based nomogram incorporating number of positive lymph nodes, Ki67 index, tumor diameter, and the presence of vascular or perineural invasion. (E) Calibration curve for predicting the probability of 5-year RFS by the MSKCC-based nomogram on the Fudan cohort. (F) Calibration curve for predicting the probability of 5-year RFS by the MSKCC-based nomogram on the external validation set. AJCC^8th, 8th edition American Joint Committee on Cancer; MSKCC, Memorial Sloan-Kettering Cancer Center; TLS, tertiary lymphoid structures; TNM, tumor-node-metastasis.